Navigation Links
Inflammatory Substance May Boost Eye Trouble
Date:10/8/2007

C-reactive protein raises odds of age-related macular degeneration, experts say

MONDAY, Oct. 8 (HealthDay News) -- People with high blood levels of C-reactive protein, a substance associated with inflammation, may be at higher risk of developing age-related macular degeneration (AMD), a major cause of vision loss in older adults.

Dutch researchers collected blood samples and took photographs of the eyes of more than 4,900 people at risk for AMD. They then followed the group for an average of 7.7 years.

During that time, 658 of the participants were diagnosed with AMD -- 561 with initial stage AMD and 97 with advanced AMD.

As an individual's C-reactive protein level increased above the midpoint of the study group, the person became more and more likely to develop AMD, the researchers found.

The study is published in the October issue of the journal Archives of Ophthalmology.

The findings suggest that lowering C-reactive protein levels may help decrease AMD risk, the study authors said.

"A substance that can selectively inhibit C-reactive protein synthesis has not yet been developed, to our knowledge," wrote a team from Erasmus Medical Center, Rotterdam. "Smoking and high body mass index increase C-reactive protein levels. Moderate alcohol intake, diets with a low glycemic index and statin [drugs] and multivitamin use reduce C-reactive protein levels."

It's known that smoking and obesity increase the risk of AMD, which occurs when the macula -- the area at the back of the retina involved in sharp vision -- deteriorates over time.

More information

The U.S. National Eye Institute has more about AMD.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Oct. 8, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Inflammatory bowel disease linked to genetic abnormality
2. Safeguarding anti-inflammatory users from ulcers
3. Gel pares inflammatory activity throughout body
4. The Usage Of Anti-Inflammatory Drugs Questioned
5. Hope For Patients With Inflammatory Bowel Disease
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. Anti-inflammatory drugs reduce the risk of oral cancer for smokers
8. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
9. Cannabinoids drug for inflammatory bowel
10. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
11. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 24, 2016 The Academy of Managed Care ... that would allow biopharmaceutical companies to more easily ... make formulary and coverage decisions, a move that addresses ... medicines. The recommendations address restrictions in the ... the drug label, a prohibition that hinders decision makers ...
Breaking Medicine Technology: